Cargando…

Efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant Gram-negative bacteria: protocol for a systematic review and meta-analysis

INTRODUCTION: Complicated urinary tract infections (cUTIs) are associated with poor prognosis. The widespread infection of multidrug-resistant Gram-negative uropathogens such as extended-spectrum beta-lactamase-producing bacteria has limited the efficacy of antibiotics used for treating cUTI. Consid...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Masayuki, Hasegawa, Takeshi, Noma, Hisashi, Ota, Erika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124262/
https://www.ncbi.nlm.nih.gov/pubmed/37085310
http://dx.doi.org/10.1136/bmjopen-2022-069166
_version_ 1785029802324918272
author Maeda, Masayuki
Hasegawa, Takeshi
Noma, Hisashi
Ota, Erika
author_facet Maeda, Masayuki
Hasegawa, Takeshi
Noma, Hisashi
Ota, Erika
author_sort Maeda, Masayuki
collection PubMed
description INTRODUCTION: Complicated urinary tract infections (cUTIs) are associated with poor prognosis. The widespread infection of multidrug-resistant Gram-negative uropathogens such as extended-spectrum beta-lactamase-producing bacteria has limited the efficacy of antibiotics used for treating cUTI. Considering the existence of antimicrobial-resistant (AMR) uropathogens, carbapenem is the last-resort antibiotic for cUTI. Given that carbapenem overuse has facilitated the spread of carbapenem-resistant Gram-negative bacteria, carbapenem dependence should be urgently reduced. However, improvement on the clinical outcomes of alternative antibiotics against cUTI caused by AMR uropathogens has not yet been systematically evaluated. Thus, this systematic review and meta-analysis aims to explore and compare the clinical outcomes of cUTI caused by AMR uropathogens between carbapenem and non-carbapenem antibiotics. METHODS AND ANALYSIS: The study inclusion criteria will be considered based on the PICO model consisting the following elements: population—adult patients with cUTIs caused by Gram-negative uropathogens; intervention—non-carbapenem class of antimicrobial agents with in vitro activities against Gram-negative uropathogens; comparison—treatment of carbapenem class antibiotics; outcome—a clinical and microbiological cure. Relevant articles published until December 2022 will be systematically searched in February 2023, using electronic databases such as PubMed, the Cochrane Library, EMBASE and ClinicalTrials.gov. Two independent reviewers will screen the select literature and then assess the full-text article to meet the inclusion criteria. The risk of bias will be assessed using the Cochrane risk-of-bias assessment tool. The treatment effects of antibiotics will be estimated as a risk ratio with a 95% CI, using the random-effects model. ETHICS AND DISSEMINATION: This protocol and systematic review will not include direct patient data; thus, informed consent will be waived. The results of this study will be published in an international peer-reviewed journal for wider information dissemination. PROSPERO REGISTRATION NUMBER: CRD42022356064.
format Online
Article
Text
id pubmed-10124262
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-101242622023-04-25 Efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant Gram-negative bacteria: protocol for a systematic review and meta-analysis Maeda, Masayuki Hasegawa, Takeshi Noma, Hisashi Ota, Erika BMJ Open Infectious Diseases INTRODUCTION: Complicated urinary tract infections (cUTIs) are associated with poor prognosis. The widespread infection of multidrug-resistant Gram-negative uropathogens such as extended-spectrum beta-lactamase-producing bacteria has limited the efficacy of antibiotics used for treating cUTI. Considering the existence of antimicrobial-resistant (AMR) uropathogens, carbapenem is the last-resort antibiotic for cUTI. Given that carbapenem overuse has facilitated the spread of carbapenem-resistant Gram-negative bacteria, carbapenem dependence should be urgently reduced. However, improvement on the clinical outcomes of alternative antibiotics against cUTI caused by AMR uropathogens has not yet been systematically evaluated. Thus, this systematic review and meta-analysis aims to explore and compare the clinical outcomes of cUTI caused by AMR uropathogens between carbapenem and non-carbapenem antibiotics. METHODS AND ANALYSIS: The study inclusion criteria will be considered based on the PICO model consisting the following elements: population—adult patients with cUTIs caused by Gram-negative uropathogens; intervention—non-carbapenem class of antimicrobial agents with in vitro activities against Gram-negative uropathogens; comparison—treatment of carbapenem class antibiotics; outcome—a clinical and microbiological cure. Relevant articles published until December 2022 will be systematically searched in February 2023, using electronic databases such as PubMed, the Cochrane Library, EMBASE and ClinicalTrials.gov. Two independent reviewers will screen the select literature and then assess the full-text article to meet the inclusion criteria. The risk of bias will be assessed using the Cochrane risk-of-bias assessment tool. The treatment effects of antibiotics will be estimated as a risk ratio with a 95% CI, using the random-effects model. ETHICS AND DISSEMINATION: This protocol and systematic review will not include direct patient data; thus, informed consent will be waived. The results of this study will be published in an international peer-reviewed journal for wider information dissemination. PROSPERO REGISTRATION NUMBER: CRD42022356064. BMJ Publishing Group 2023-04-21 /pmc/articles/PMC10124262/ /pubmed/37085310 http://dx.doi.org/10.1136/bmjopen-2022-069166 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Infectious Diseases
Maeda, Masayuki
Hasegawa, Takeshi
Noma, Hisashi
Ota, Erika
Efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant Gram-negative bacteria: protocol for a systematic review and meta-analysis
title Efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant Gram-negative bacteria: protocol for a systematic review and meta-analysis
title_full Efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant Gram-negative bacteria: protocol for a systematic review and meta-analysis
title_fullStr Efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant Gram-negative bacteria: protocol for a systematic review and meta-analysis
title_full_unstemmed Efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant Gram-negative bacteria: protocol for a systematic review and meta-analysis
title_short Efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant Gram-negative bacteria: protocol for a systematic review and meta-analysis
title_sort efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant gram-negative bacteria: protocol for a systematic review and meta-analysis
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124262/
https://www.ncbi.nlm.nih.gov/pubmed/37085310
http://dx.doi.org/10.1136/bmjopen-2022-069166
work_keys_str_mv AT maedamasayuki efficacyofcarbapenemsversusalternativeantimicrobialsfortreatingcomplicatedurinarytractinfectionscausedbyantimicrobialresistantgramnegativebacteriaprotocolforasystematicreviewandmetaanalysis
AT hasegawatakeshi efficacyofcarbapenemsversusalternativeantimicrobialsfortreatingcomplicatedurinarytractinfectionscausedbyantimicrobialresistantgramnegativebacteriaprotocolforasystematicreviewandmetaanalysis
AT nomahisashi efficacyofcarbapenemsversusalternativeantimicrobialsfortreatingcomplicatedurinarytractinfectionscausedbyantimicrobialresistantgramnegativebacteriaprotocolforasystematicreviewandmetaanalysis
AT otaerika efficacyofcarbapenemsversusalternativeantimicrobialsfortreatingcomplicatedurinarytractinfectionscausedbyantimicrobialresistantgramnegativebacteriaprotocolforasystematicreviewandmetaanalysis